poisar

Stock

Travere Therapeutics, Inc. TVTX

$67.68+0.80%

Overview

TVTX market data

Price History

TVTX price chart · 1M
O
66.34
H
67.81
L
66.34
C
67.68
Vol
28,694.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$66.34
Previous Close
$67.14
Day High
$67.81
Day Low
$66.34
52 Week High
$67.81
52 Week Low
$39.80
7 Day Return
+5.05%
30 Day Return
+21.03%
90 Day Return
+43.42%
1 Year Return
+68.74%
Daily Notional Volume
$1.9M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.29
Diluted earnings per share over the trailing twelve months.
Beta
1.11
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-7.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$17.05 – $67.50
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $5.8B · P/B 29.77 · P/S 9.79.

Company News

10 captured
Evercore ISI Group Maintains Outperform on Travere Therapeutics, Raises Price Target to $78Benzinga · Aug 10, 2026, 4:38 PM
Canaccord Genuity Maintains Buy on Travere Therapeutics, Raises Price Target to $70Benzinga · Aug 6, 2026, 11:08 PM
Wedbush Maintains Outperform on Travere Therapeutics, Raises Price Target to $75Benzinga · Aug 6, 2026, 3:48 PM
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $75Benzinga · Aug 5, 2026, 7:45 PM
Citigroup Maintains Buy on Travere Therapeutics, Raises Price Target to $85Benzinga · Aug 5, 2026, 6:31 PM
Evercore ISI Group Maintains Outperform on Travere Therapeutics, Raises Price Target to $68Benzinga · Aug 5, 2026, 3:37 PM
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On WednesdayBenzinga · Aug 5, 2026, 2:01 PM
Guggenheim Maintains Buy on Travere Therapeutics, Raises Price Target to $75Benzinga · Aug 5, 2026, 1:59 PM
Travere Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 5, 2026, 11:42 AM
Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going OnBenzinga · Aug 5, 2026, 7:16 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Travere Therapeutics, Inc. (TVTX) stock — price, valuation & news | Poisar